With a focus on targets relevant to CLL, the expression of UGT2B17 correlated well with that of multiple target genes of NF-κB and STAT3, including the NF-κB targets IL15, TNFSF10, NQO1, MYD88, CD40 and CFLAR (encoding cFLIP), and the STAT3 targets lipoprotein lipase (LPL), GAB1, TNRRFS1A and WNT5A, among others (Fig. 4C). Here, UGT2B17 is linked to B-cell chronic lymphocytic leukemia.